Listed MedTech TruSpine scrambles for survival

Listed MedTech TruSpine has reported another year of losses as it scrambles for survival. For the year ended 29th March 2023, the pre-revenue company lost £853,000 before tax – compared with £941,000 in 2022 – with an R&D tax credit of £199,000 taking loss after tax to £654,000. The firm stated this morning: “The group … Continue reading Listed MedTech TruSpine scrambles for survival